Skip to main content
OpenTrials
Completed

NCT Number: NCT03480542

Central Venous Access Study

The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD catheters by way of a structured retrospective review of the Electronic Medical Record (EMR) system.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Central Line Catheters

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

About this study

This will be a single site retrospective (non-experimental) study utilizing the electronic medical record, both descriptive and correlational methods.

There will be two outcomes:

  • The outcomes associated with the management of Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD) Catheter in adherence with hospital approved Evidence-based Practice guidelines for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD) Catheter.
  • The mechanical/technical, thrombotic, and other adverse outcomes (Heparin induced coagulopathy) associated with central venous catheters due to variation in insertion and management practices of Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD) Catheter.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients in Medical Intensive Care Unit (MICU), Coronary Care Unit (CCU), Cardiac Surgical Intensive Care Unit (CSICU), Surgical Intensive Care Unit (SICU) with either CVCs, PICCs, or HD catheters.

Exclusion criteria

  • Pediatric (including neonates), obstetric and gynecology, medical-surgical, and oncology patients.

Treatment and study plan

Primary outcomes

  1. Adherence to Clinical Guidelines for Catheter Interventions and Management

    Time frame: 1 year

    Number of medical records with documented mechanical/technical, thrombotic, and other adverse outcomes associated with use of CVCs, PICCs, and Hemodialysis (HD) catheters.

Secondary outcomes

  1. Number of Documented Catheter Complications

    Time frame: 1 year

    Number of medical records with documented complications associated with the use of CVCs, PICCs, and Hemodialysis (HD) catheters

Sponsors and collaborators

Lead sponsor

Hackensack Meridian Health

Other

Registry information

Official study title

The CentrAl VenouS Catheter Access DocumEntation (CASCADE) Study

Acronym: CASCADE

Important dates

Study start
2017
Primary completion
2022
Study completion
2022
First posted
Mar 29, 2018
Registry last updated
Jun 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.